Viridian Therapeutics Inc. (VRDN) Rise 0.48% in Day Trading, Closes at $24.88

The price of Viridian Therapeutics Inc. (NASDAQ: VRDN) closed at $24.88 in the last session, up 0.48% from day before closing price of $24.76. In other words, the price has increased by $+0.12 from its previous closing price. On the day, 767812 shares were traded. VRDN stock price reached its highest trading level at $25.16 during the session, while it also had its lowest trading level at $24.45.

Top 5 EV Tech Stocks to Buy for 2023

According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.

Click Here to Download the FREE Report.



We take a closer look at VRDN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.90 and its Current Ratio is at 12.90. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.

Upgrades & Downgrades

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Apr 12 when Myers Scott Dunseth bought 4,000 shares for $25.37 per share. The transaction valued at 101,479 led to the insider holds 259,500 shares of the business.

Myers Scott Dunseth bought 5,500 shares of VRDN for $160,324 on Mar 13. The Chief Executive Officer now owns 255,500 shares after completing the transaction at $29.15 per share. On Mar 09, another insider, Meisner Lara, who serves as the General Counsel and Secretary of the company, sold 29,971 shares for $29.07 each. As a result, the insider received 871,257 and left with 0 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1.01B and an Enterprise Value of 776.96M. For the stock, the TTM Price-to-Sale (P/S) ratio is 617.02 while its Price-to-Book (P/B) ratio in mrq is 4.88. Its current Enterprise Value per Revenue stands at 469.75 whereas that against EBITDA is -4.53.

Stock Price History:

Over the past 52 weeks, VRDN has reached a high of $39.00, while it has fallen to a 52-week low of $9.84. The 50-Day Moving Average of the stock is 26.19, while the 200-Day Moving Average is calculated to be 26.02.

Shares Statistics:

According to the various share statistics, VRDN traded on average about 594.51K shares per day over the past 3-months and 790.88k shares per day over the past 10 days. A total of 42.24M shares are outstanding, with a floating share count of 39.68M. Insiders hold about 1.91% of the company’s shares, while institutions hold 95.00% stake in the company. Shares short for VRDN as of Apr 27, 2023 were 3.49M with a Short Ratio of 3.49M, compared to 3.45M on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 8.09% and a Short% of Float of 8.36%.

Earnings Estimates

The company has 12 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$1.27 for the current quarter, with a high estimate of -$0.87 and a low estimate of -$1.69, while EPS last year was -$1.06. The consensus estimate for the next quarter is -$1.19, with high estimates of -$0.87 and low estimates of -$1.47.

Analysts are recommending an EPS of between -$4.33 and -$6.15 for the fiscal current year, implying an average EPS of -$5.35. EPS for the following year is -$4.77, with 12 analysts recommending between -$3.54 and -$5.89.